Genetics and Molecular Research · 2008 · 11 citations · 27 references
Life SciencesGeneticsMolecular BiologyGene ExpressionMolecular VirologyTranscriptional RegulationEnhancer ArchitectureEnhancer FunctionGene Expression RegulationChimeric Viral VectorsEnhancer-mediated ExpressionFactor ViiaFactor Viii ActivationFactor Viiia ComplexLocus Control RegionsPromoter Enhancer ElementsViral Expression Vectors
We explored the potential of fusion of hepatic locus control region 1 (HCR-1) with HCR-2 to express B-domain-deleted human factor VIII (FVIII) in four cell lines. B-domain-deleted human FVIII expression was controlled by HCR-1/HCR-2, followed by liver specific and ubiquitous promoters. Chimera enhancer HCR-1/HCR-2, followed by cytomegalovirus (CMV) promoter, gave 2-fold more FVIII expression in all cell lines (105.6 +/- 2.8 for Hek-293, 68.8 +/- 3.8 for HepG2, 34.8 +/- 1.3 for CHO, and 27.2 +/- 1.6 ng x mL(-1) x 10(6) cells(-1) for L.N.) when compared to the vector with CMV alone (54.8 +/- 3.3 for Hek-293, 32.4 +/- 1.2 for HepG2, 18.6 +/- 1.1 for CHO, and 10.1 +/- 1.7 ng x mL(-1) x 10(6) cells(-1) for L.N.). Elongation factor 1-alpha gene and human CMV promoters were more efficient than the promoters from the human alpha-1-antitrypsin gene, and fviii was less efficient in hepatic cell lines. HCR-1/HCR-2, followed by strong promoters, increases FVIII expression in vitro. Our results underscore the importance of cis sequences for enhancing in vitro FVIII expression; this may be helpful for designing new strategies to improve heterologous expression systems.
27
Characterization of the human factor VIII gene
Jane Gitschier, William I. Wood, Therese M. Goralka et al. · Nature · 1984 · 995 citations